Oxford Biomaterials Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Oxford Biomaterials General Information

Description

Developer of silk purifying technologies designed to offer silk life cycle consultancy service. The company's technologies use biomimetic spinning technology to create fiber from natural or artificial proteins, based on the principles used by spiders and insects to create natural silk fiber, thereby enabling users to be ensured of the quality and sustainability of silk products.

Contact Information

Formerly Known As
Spinox, Deneflex
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Magdalen Centre, Oxford Science Park
  • Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01869
Primary Industry
Synthetic Textiles
Other Industries
Biotechnology
Corporate Office
  • Magdalen Centre, Oxford Science Park
  • Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01869

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Biomaterials Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-Apr-2021 Completed Generating Revenue
7. Grant 01-Dec-2015 Completed Generating Revenue
6. Grant 01-Jul-2015 Completed Generating Revenue
5. Grant 01-Nov-2013 Completed Generating Revenue
4. Grant 31-Mar-2008 Completed Generating Revenue
3. Early Stage VC 03-Feb-2003 Completed Startup
2. Early Stage VC 04-Mar-2002 $498K $498K Completed Startup
1. University Spin-Out 19-Oct-2001 Completed Startup
To view Oxford Biomaterials’s complete valuation and funding history, request access »

Oxford Biomaterials Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Oxford Biomaterials’s complete cap table history, request access »

Oxford Biomaterials Patents

Oxford Biomaterials Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201522900-D0 Silk proteins Inactive 24-Dec-2015
EP-2741791-A1 Medical device Active 11-Aug-2011
EP-2741791-B1 Medical device Active 11-Aug-2011
GB-201113856-D0 Medical device Inactive 11-Aug-2011
US-20140288638-A1 Medical device Active 11-Aug-2011 A61F13/511
To view Oxford Biomaterials’s complete patent history, request access »

Oxford Biomaterials Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Biomaterials Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
European Commission Government
Technology Strategy Board (TSB) Corporation Minority
University of Oxford University Minority
To view Oxford Biomaterials’s complete investors history, request access »

Oxford Biomaterials FAQs

  • When was Oxford Biomaterials founded?

    Oxford Biomaterials was founded in 2001.

  • Where is Oxford Biomaterials headquartered?

    Oxford Biomaterials is headquartered in Oxford, United Kingdom.

  • What is the size of Oxford Biomaterials?

    Oxford Biomaterials has 4 total employees.

  • What industry is Oxford Biomaterials in?

    Oxford Biomaterials’s primary industry is Synthetic Textiles.

  • Is Oxford Biomaterials a private or public company?

    Oxford Biomaterials is a Private company.

  • What is Oxford Biomaterials’s current revenue?

    The current revenue for Oxford Biomaterials is .

  • How much funding has Oxford Biomaterials raised over time?

    Oxford Biomaterials has raised $726K.

  • Who are Oxford Biomaterials’s investors?

    Innovate UK, European Commission, Technology Strategy Board (TSB), and University of Oxford have invested in Oxford Biomaterials.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process